Angels for Change has been working closely with the FDA to communicate updates on the recently reported chemotherapy shortages. We are pleased to announce that the FDA has worked with Qilu Pharmaceuticals and Apotex Corp. to temporarily import cisplatin to help meet patient needs during this current shortage crisis.

According to the FDA, “in this situation, we very carefully assess the overseas product for quality, making sure that its safe for U.S. patients. Please see the entry in our drug shortages database as well as the “Dear Health Care Provider” letter regarding this action. We will continue all efforts with the approved manufacturers in addition to any potential importation efforts to meet all patient needs for the oncology drugs impacted by shortages.”

Please contact us if you are a patient or family who has questions or needs support.